Immunocytometric determination of the α and β isoforms of human DNA topoisomerase II: Influence of different fixatives

Analytical Cellular Pathology

Volumn 10, Issue 2, 1996, Pages 137-148

  Prosperi, Ennio ^a   Negri, Claudia ^b   Bottiroli, Giovanni ^a   Astaldi Ricotti, Giulia C B ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b CNR   (Italy)

Author keywords

Cell cycle distribution; DNA topoisomerase II and ; Immunocytometry; Proliferation markers

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL CYCLE; DNA TOPOISOMERASES, TYPE II; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT DYES; HELA CELLS; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICE;

EID: 0029971702     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Adachi Y, Luke M, Laemmli UK. Chromosome assembly in vitro: topoisomerase II is required for condensation. Cell 1991;64:137-148.
2. Berrios M, Osheroff N, Fischer PA. In situ localization of DNA topoisomerase II, a major polypeptide component of Drosophila nuclear matrix fraction. Proc Natl Acad Sci USA 1985;82:4142-4146.
3. Charron M, Hancock R. DNA topoisomerase II is required for formation of mitotic chromosomes in chinese hamster ovary cells: studies using the inhibitor 4′-demethylepi-podophyllotoxin 9-(4,6-O-thenylidene-β-D-glucopyranoside). Biochemistry 1990;29:9531-9537.
4. Chung TDY, Drake FH, Tan KB, Per SR, Crooke ST. Characterization and immunological identification of cDNA clones encoding two human topoisomerase II isozymes. Proc Natl Acad Sci USA 1989;86:9431-9435.
5. Clevenger CV, Bauer KD, Epstein AL. A method for simultaneous nuclear immunofluorescence and DNA content quantification using monoclonal antibodies and flow cytometry. Cytometry 1985;6:208-214.
6. Coutts J, Plumb JA, Brown R, Keith WN. Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes. Br J Cancer 1993;68:793-800.
7. DiNardo S, Voelkel JC, Sternglanz R. DNA topoisomerase II mutant of Saccharomyces cerevisiae; topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 1984;81:2616-2620.
8. Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 1989;28:8154-8160.
9. Earnshaw WC, Halligan B, Cooke CA, Heck MMS, Liu LF. Topoisomerase II is a structural component of mitotic chromosome scaffold. J Cell Biol 1985;100:1706-1715.
10. Feldhoff PW, Mirski SEL, Cole SPC, Sullivan DM. Altered subcellular distribution of topoisomerase IIα in a drug-resistant human small cell lung cancer cell line. Cancer Res 1994;54:756-762.
11. Harker WG, Slade DL, Drake FH, Parr RL. Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase IIβ isoform. Biochemistry 1991;30:9953-9961.
12. Heck MMS, Earnshaw WC. Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 1986;103:2569-2581.
13. Heck MMS, Hittelman WN, Earnshaw WC. Differential expression of DNA topoisomerase I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 1988;85:1086-1090.
14. Hochhauser D, Harris AL. The role of topoisomerase IIα and β in drug resistance. Cancer Treat Rev 1993;19:181-194.
15. Holm C, Goto T, Wang JC, Botstein D. DNA topoisomerase II is required at the time of mitosis in yeast. Cell 1985;41:553-563.
16. Hsiang YH, Wu HY, Liu LF. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res 1988;48:3230-3235.
17. Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ. Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Cancer Res 1991;51:3534-3543.
18. Kaufmann SH, Shaper JH. Association of topoisomerase II with the hepatoma cell nuclear matrix: the role of intermolecular disulfide bond formation. Exp Cell Res 1991;192:511-523.
19. Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NM, Astaldi Ricotti GCB. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes. Exp Cell Res 1992;200:452-459.
20. Negri C, Scovassi AI, Braghetti A, Guano F, Astaldi Ricotti GCB. DNA topoisomerase IIβ stability and distribution in different animal cells in comparison to DNA topoisomerase I and IIα. Exp Cell Res 1993;206:128-133.
21. Petrov P, Drake FH, Loranger A, Huang W, Hancock R. Localization of DNA topoisomerase II in chinese hamster fibroblasts by confocal and electron microscopy. Exp Cell Res 1993;204:73-81.
22. Prosperi E, Negri C, Marchese G, Astaldi Ricotti GCB. Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes. Cell Prolif 1994;27:257-267.
23. Prosperi E, Sala E, Negri C, Oliani C, Supino R, Astaldi Ricotti GCB, Bottiroli G. Topoisomerase IIα and β in human tumour cells grown in vitro and in vivo. Anticancer Res 1992;12:2093-2099.
24. 2 in human primary brest cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. Oncogene 1993;8:933-938.
25. Smith PJ, Makinson TA. Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line. Cancer Res 1989;49:1118-1124.
26. Sullivan DM, Lathman MD, Ross WE. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and chinese hamster ovary cells. Cancer Res 1987;47:3973-3979.
27. Taagepera S, Rao PN, Drake FH, Gorbsky GJ. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc Natl Acad Sci USA 1993;90:8407-8411.
28. Tan KB, Dorman TE, Falls KM, Chung TDY, Mirabelli CK, Crooke ST, Mao JI. Topoisomerase IIα and topoisomerase IIβ genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res 1992;52:231-234.
29. Tandou G, Mirambeau G, Lavenot C, derGarabedian A, Vermeersch J, Duguet M. DNA topoisomerase activities in concanavalin A-stimulated lymphocytes. FEBS Lett 1984;176:431-435.
30. Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. Pombe. Cell 1987;50:917-925.
31. Van der Zee AGJ, de Jong S, Keith WN, Hollema H, Boonstra H, de Vries GE. Quantitative and qualitative aspects of topoisomerase I and IIα and β in untreated and platinum/cyclophosphamide treated malignant ovarian tumours. Cancer Res 1994;54:749-755.
32. Woessner RD, Chung TDY, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II. Cancer Res 1990;50:2901-2908.
33. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Diff 1991;2:209-214.
34. Wood ER, Earnshaw WC. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J Cell Biol 1990;111:2839-2850.
35. Zini M, Martelli AM, Sabatelli P, Santi S, Negri C, Astaldi Ricotti GCB, Maraldi NM. The 180-kDa isoform of topoisomerase II is localised in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp Cell Res 1992;200:460-466.
36. Zini N, Santi S, Ognibene A, Bavelloni A, Neri LM, Valmori A, Mariani E, Negri C, Astaldi Ricotti GCB, Maraldi NM. Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Exp Cell Res 1994;210:336-348.